128 related articles for article (PubMed ID: 10436799)
1. Detection of micrometastasis in bone marrow of pancreatic cancer patients.
Thorban S; Roder JD; Siewert JR
Ann Oncol; 1999; 10 Suppl 4():111-3. PubMed ID: 10436799
[TBL] [Abstract][Full Text] [Related]
2. Micrometastases in bone marrow: prognostic indicators for pancreatic cancer.
Roder JD; Thorban S; Pantel K; Siewert JR
World J Surg; 1999 Sep; 23(9):888-91. PubMed ID: 10449815
[TBL] [Abstract][Full Text] [Related]
3. [Immunocytochemical detection and prognostic significance of epithelial tumor cells in bone marrow of patients with pancreatic carcinoma].
Thorban S; Roder JD; Pantel K; Siewert JR
Zentralbl Chir; 1996; 121(6):487-9; discussion 490-2. PubMed ID: 8767337
[TBL] [Abstract][Full Text] [Related]
4. Disseminated epithelial tumor cells in bone marrow of patients with esophageal cancer: detection and prognostic significance.
Thorban S; Roder JD; Nekarda H; Funk A; Pantel K; Siewert JR
World J Surg; 1996 Jun; 20(5):567-72; discussion 572-3. PubMed ID: 8661632
[TBL] [Abstract][Full Text] [Related]
5. Epithelial tumour cells in bone marrow of patients with pancreatic carcinoma detected by immunocytochemical staining.
Thorban S; Roder JD; Pantel K; Siewert JR
Eur J Cancer; 1996 Feb; 32A(2):363-5. PubMed ID: 8664055
[TBL] [Abstract][Full Text] [Related]
6. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow.
Pantel K; Schlimok G; Angstwurm M; Weckermann D; Schmaus W; Gath H; Passlick B; Izbicki JR; Riethmüller G
J Hematother; 1994; 3(3):165-73. PubMed ID: 7530132
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma.
Thorban S; Roder JD; Nekarda H; Funk A; Siewert JR; Pantel K
J Natl Cancer Inst; 1996 Sep; 88(17):1222-7. PubMed ID: 8780632
[TBL] [Abstract][Full Text] [Related]
8. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators.
Hofmann T; Riesenberg R; Buchner A; Zimmermann W; Hofstetter A; Oberneder R
J Urol; 2003 Apr; 169(4):1303-7. PubMed ID: 12629348
[TBL] [Abstract][Full Text] [Related]
9. Frequency and prognostic relevance of disseminated tumor cells in bone marrow of patients with metastatic renal cell carcinoma.
Buchner A; Riesenberg R; Kotter I; Hofstetter A; Stief C; Oberneder R
Cancer; 2006 Apr; 106(7):1514-20. PubMed ID: 16518813
[TBL] [Abstract][Full Text] [Related]
10. Occult tumor cells in bone marrow of patients with locoregionally restricted ovarian cancer predict early distant metastatic relapse.
Braun S; Schindlbeck C; Hepp F; Janni W; Kentenich C; Riethmüller G; Pantel K
J Clin Oncol; 2001 Jan; 19(2):368-75. PubMed ID: 11208828
[TBL] [Abstract][Full Text] [Related]
11. Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer.
Pantel K; Izbicki JR; Angstwurm M; Braun S; Passlick B; Karg O; Thetter O; Riethmüller G
Cancer Res; 1993 Mar; 53(5):1027-31. PubMed ID: 7679945
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical detection of isolated epithelial tumor cells in bone marrow of patients with pancreatic carcinoma.
Thorban S; Roder JD; Pantel K; Siewert JR
Am J Surg; 1996 Sep; 172(3):297-8. PubMed ID: 8862089
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical monitoring of micrometastatic disease: reduction of prostate cancer cells in bone marrow by androgen deprivation.
Pantel K; Enzmann T; Köllermann J; Caprano J; Riethmüller G; Köllermann MW
Int J Cancer; 1997 May; 71(4):521-5. PubMed ID: 9178803
[TBL] [Abstract][Full Text] [Related]
14. Does the immunocytochemical detection of epithelial cells in bone marrow (micrometastasis) influence the time to biochemical relapse after radical prostatectomy?
Weckermann D; Wawroschek F; Krawczak G; Haude KH; Harzmann R
Urol Res; 1999 Oct; 27(5):285-90. PubMed ID: 10644227
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
Braun S; Pantel K; Müller P; Janni W; Hepp F; Kentenich CR; Gastroph S; Wischnik A; Dimpfl T; Kindermann G; Riethmüller G; Schlimok G
N Engl J Med; 2000 Feb; 342(8):525-33. PubMed ID: 10684910
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells.
Pantel K; Schlimok G; Braun S; Kutter D; Lindemann F; Schaller G; Funke I; Izbicki JR; Riethmüller G
J Natl Cancer Inst; 1993 Sep; 85(17):1419-24. PubMed ID: 7688814
[TBL] [Abstract][Full Text] [Related]
17. Detection and prognostic value of cytokeratin positive tumor cells in bone marrow of patients with renal cell carcinoma.
Buchner A; Riesenberg R; Kotter I; Crispin A; Hofstetter A; Oberneder R
J Urol; 2003 Nov; 170(5):1747-51. PubMed ID: 14532768
[TBL] [Abstract][Full Text] [Related]
18. Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern.
Effenberger KE; Borgen E; Eulenburg CZ; Bartkowiak K; Grosser A; Synnestvedt M; Kaaresen R; Brandt B; Nesland JM; Pantel K; Naume B
Breast Cancer Res Treat; 2011 Feb; 125(3):729-38. PubMed ID: 20449649
[TBL] [Abstract][Full Text] [Related]
19. [Immunocytologic detection of disseminated tumor cells in the peritoneal cavity and bone marrow in patients with pancreatic carcinoma].
Juhl H; Kalthoff H; Krüger U; Schott A; Schreiber HW; Henne-Bruns D; Kremer B
Chirurg; 1994 Dec; 65(12):1111-5. PubMed ID: 7851144
[TBL] [Abstract][Full Text] [Related]
20. Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients.
Braun S; Kentenich C; Janni W; Hepp F; de Waal J; Willgeroth F; Sommer H; Pantel K
J Clin Oncol; 2000 Jan; 18(1):80-6. PubMed ID: 10623696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
